“Idiopathic sudden sensorineural hearing loss (ISSHL) is the newest indication approved by the Undersea and Hyperbaric Medical Society’s Hyperbaric Oxygen Therapy Committee” Sound research combined with clinical efficacy has bolstered the use of hyperbaric oxygen therapy for this condition. It gives us new hope in the hyperbaric industry that more conditions can follow and get recognized for the many indications that have been shown in recent literature, combined with the results seen in many of the private hyperbaric centers throughout the world <view study>

59 patients with sudden sensorineural hearing loss were given hyperbaric oxygen therapy and all improved. However, if given within the first 14 days following hearing loss, better prognosis was noted <view study>

Following the diagnosis of sudden hearing loss, corticosteroid therapy is typically recommended immediately with favorable results. However, for those that do not respond to this therapy, there is now hope with the addition of hyperbaric oxygen therapy. This simple and safe procedure has helped in many cases of hearing loss, particularly for those that have failed with corticosteroid therapy <view study>

Review of literature from 2004 to 2019 show significant improvements when hyperbaric oxygen therapy is administered following acoustic trauma. Typically, first line therapy is to provide corticosteroid therapy and if no response is seen in 7 days, then hyperbaric therapy should immediately be deployed <view study>